Background Thyroid cancer is the most common malignancy of the endocrine system,
representing 3.8% of all new cancer cases in the United States and is the ninth most …

Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising
incidence in the past 20 years. Surgery is the primary strategy of therapy for patients with …

The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the
management of different types of thyroid carcinoma, including papillary, follicular, Hürthle …

Background Annotations of the phylogenetic tree of the human kinome is an intuitive way to
visualize compound profiling data, structural features of kinases or functional relationships …

Background Chemotherapy has historically proven ineffective in advanced differentiated
thyroid cancers, but the realisation that various tyrosine kinases are activated in the disease …

Background: Detectable serum thyroglobulin (Tg) in patients with papillary thyroid
carcinoma (PTC) after total thyroidectomy implies unsuccessful surgery, indicating a high …

Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the differentiation of follicular adenoma from follicular carcinoma. Explain novel …

Background: Clinical benefit from cytotoxic chemotherapy for metastatic papillary thyroid
carcinoma (PTC) is disappointing, and effective therapeutic approaches for these patients …

These NCCN Guidelines Insights focus on some of the major updates to the 2014 NCCN
Guidelines for Thyroid Carcinoma. Kinase inhibitor therapy may be used to treat thyroid …

Whereas preemptive screening for the presence of lymph node and lung metastases is
standard-of-care in thyroid cancer patients, bone metastases are less well studied and are …